LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.16 misses by $0.03 revenue of $0.03M misses by $0.02M March, 02 2023 04:01 PM Lexicon Pharmaceuticals Inc. Lexicon Pharmaceuticals press release ( NASDAQ: LXRX ): Q4 GAAP EPS of -$0.16 misses by $0.03 . Revenue of $0.03M (+200.0% Y/Y) misses by $0.02M . For further details see: Lexicon Pharmaceuticals GAAP EPS of -$0.16 misses by $0.03, revenue of $0.03M misses by $0.02M